Skip to main content
. 2017 Aug 18;36(12):2655–2665. doi: 10.1007/s10067-017-3788-1

Table 1.

Baseline patient characteristics by BMI

SC abatacept IV abatacept Pooled SC/IV abatacept
Underweight/
normal BMI
n = 265
Overweight BMI
n = 249
Obese BMI
n = 221
Underweight/
normal BMI
n = 261
Overweight BMI
n = 248
Obese BMI
n = 212
Underweight/
normal BMI
n = 526
Overweight BMI
n = 497
Obese BMI
n = 433
BMI, kg/m2 22.0 (2.2) 27.2 (1.4) 35.2 (5.1) 22.0 (2.1) 27.5 (1.5) 35.3 (5.4) 22.0 (2.1) 27.4 (1.4) 35.2 (5.2)
Age, years 46.0 (14.3) 51.4 (12.4) 53.0 (11.4) 49.0 (14.3) 51.2 (12.1) 50.1 (10.7) 47.5 (14.4) 51.3 (12.2) 51.6 (11.2)
Females, % 84.9 78.7 90.0 81.2 79.0 81.1 83.1 78.9 85.7
Caucasians, % 72.1 77.1 75.1 69.7 75.4 79.2 70.9 76.3 77.1
RA duration, years 8.2 (8.0) 7.1 (6.8) 7.6 (9.4) 8.3 (8.3) 8.2 (8.2) 6.2 (6.6) 8.3 (8.2) 7.7 (7.5) 6.9 (8.2)
TJC28 16.4 (6.6) 17.0 (6.4) 17.5 (6.2) 16.3 (6.6) 16.9 (6.4) 17.3 (6.3) 16.3 (6.6) 16.9 (6.4) 17.4 (6.2)
SJC28 14.2 (5.8) 14.0 (5.4) 14.6 (5.5) 13.8 (5.4) 14.2 (5.5) 13.6 (5.1) 14.0 (5.6) 14.1 (5.4) 14.1 (5.3)
hsCRP, mg/dL 3.2 (3.6) 2.5 (2.5) 2.1 (2.3) 3.0 (3.3) 2.5 (2.7) 2.6 (2.8) 3.1 (3.4) 2.5 (2.6) 2.3 (2.5)
HAQ-DI 1.7 (0.7) 1.7 (0.7) 1.8 (0.7) 1.6 (0.7) 1.7 (0.7) 1.7 (0.7) 1.7 (0.7) 1.7 (0.7) 1.8 (0.7)
DAS28 (CRP) 6.3 (0.9) 6.2 (0.9) 6.3 (0.8) 6.2 (0.8) 6.2 (0.9) 6.3 (0.8) 6.2 (0.9) 6.2 (0.9) 6.3 (0.8)
PtGA, 100 mm VAS 67.8 (19.1) 65.8 (20.6) 66.7 (21.6) 64.8 (19.9) 64.0 (19.9) 66.3 (20.2) 66.3 (19.5) 64.9 (20.3) 66.5 (20.9)

Data are mean (standard deviation) unless indicated otherwise

BMI body mass index, CRP C-reactive protein, DAS28 Disease Activity Score 28, HAQ-DI Health Assessment Questionnaire-Disability Index, hsCRP high-sensitivity CRP, IV intravenous, PtGA patient global assessment, RA rheumatoid arthritis, SC subcutaneous, SJC28 swollen joint count-28 joints, TJC28 tender joint count-28 joints, VAS visual analogue scale